As of 4:00pm ET
| +0.01 / +0.75%|
Bio-Path Holdings, Inc. is a clinical stage biotechnology company, which focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology designed to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous infusion. The company has drug delivery platform technology with composition of matter intellectual property for systemic delivery of antisense. Bio-Path Holdings was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Maria Tari in May 2007 and is headquartered in Bellaire, TX.
|Peter H. Nielsen||Chairman, President, CEO, CFO, Treasurer & CAO|
|Ulrich W. Mueller||Chief Operating Officer & Secretary|
|Ana Maria Tari||Director-Preclinical Operations & Research|
|Tara Sadeghi||Director-Clinical Operations|